首页   按字顺浏览 期刊浏览 卷期浏览 Pharmacokinetics of Oral AcetylcysteineAbsorption, Binding and Metabolism in Patients w...
Pharmacokinetics of Oral AcetylcysteineAbsorption, Binding and Metabolism in Patients with Respiratory Disorders

 

作者: D. Rodenstein,   A. De Coster,   A. Gazzaniga,  

 

期刊: Clinical Pharmacokinetics  (ADIS Available online 1978)
卷期: Volume 3, issue 3  

页码: 247-254

 

ISSN:0312-5963

 

年代: 1978

 

出版商: ADIS

 

数据来源: ADIS

 

摘要:

The fate of an oral 100mg dose of35S-acetylcysteine, a mucolytic agent, was studied in 10 patients with respiratory disorders, 5 of whom underwent pneumonectomy or lobectomy a few hours after administration of the drug. In the 5 nonoperated patients, plasma radioactivity concentrations were maximal after 2 to 3 hours and remained high after 24 hours; about 22% of radioactivity was excreted in urine after 24 hours. In the 5 operated patients, plasma radioactivity concentrations were comparable with those in the nonoperated patients. Lung tissue radioactivity concentrations after 5 hours were comparable with those in plasma, while the presence of small amounts of radioactivity in the bronchial secretions indicates that acetylcysteine passes into the mucus.Total radioactivity after 5 hours consisted of free, unchanged drug and metabolites (about 22% of total in plasma, 48% in lung tissue), unchanged drug bound to protein by means of labile disulphide bridges (about 14% in plasma, 47% in lung tissue), and drug firmly bound to protein (about 64% in plasma, 5% in lung tissue).Oral acetylcysteine is rapidly absorbed and slowly excreted and is available in the lung in an active form for at least 5 hours at high concentrations.

 

点击下载:  PDF (374KB)



返 回